HEC Group and JungKwanJang Form Strategic Alliance to Drive a New Era in Eastern Tonic Health

SINGAPORE, Aug. 29, 2025 /PRNewswire/ -- The JungKwanJang delegation included Kim Yang-jin, Director General of the Overseas Business Division; Jung Jong, Director General of the Asia-Pacific Business Division; and Kim Jong-sik, Director of the Future Business Research Institute, along with five other representatives. HEC Group was represented by Director and General Manager Tang Xinfa; Lu Yuxin, Director and General Coordinator of the Health Industry; Li Wenjia, Deputy General Coordinator of the Health Industry and Dean of the Health Research Institute; Chen Hao, General Manager of HEC Pharmacy Chain Sales; Chen Junhao, among other corporate leaders.

Key Focal Discussions: Powerful Alliance Launches a New Chapter in the Global Health Industry

During the meeting, both sides shared their core strengths and strategies. Tang Xinfa, Director and General Manager of HEC Group, highlighted the company's focus on ecological breeding and scientific innovation of Cordyceps sinensis, while expanding its market applications. Through premium brand HEC Fresh Cordyceps and national brand HEC Buji, the group pursues its vision of "making high-quality Cordyceps accessible to all." With aligned visions and strategies, both parties look forward to synergizing across products, channels, and branding to advance the global health industry.

JungKwanJang representatives highlighted their pursuit of partners with innovation, quality, and cultural influence. Recognizing HEC Group as a global leader in ecological Cordyceps with strong achievements in research, quality, and tonic culture, they see it as an ideal partner. Together, the "Red Ginseng + Cordyceps" synergy is expected to bring the health benefits of modern technology and traditional tonics to more consumers worldwide.

Through this partnership, the two parties will establish a comprehensive strategic collaboration, leveraging their core strengths in ecological Cordyceps sinensis breeding R&D and Korean red ginseng health products. Together, they will drive the global development of premium health products.

International Perspective: Mutual Empowerment to Boost Global Branding

Amid globalization, Chinese enterprises are advancing globally with products as the foundation, brands as the wings, and culture as the soul. Within this framework, HEC Group is building a health ecosystem that bridges tradition and modernity, domestic and international markets, with Cordyceps sinensis at its core.

As a national health brand with global reach, HEC Cordyceps has steadily advanced its international strategy—partnering with the Boao Forum for Asia, appearing at high-level platforms such as the China-Arab States Cooperation Forum, and hosting the Summit Forum on Cordyceps Brand Internationalization to engage leading experts on global development.

Through this collaboration, both sides will leverage their global strengths—JungKwanJang 's presence in over 40 countries and regions and HEC Group's extensive pharmaceutical and wellness network—to accelerate cross-border circulation of health products. They will drive joint marketing, co-branded products, and expansion in China and abroad, further enhancing both brands' global influence.

Forward-looking Layout: Upgrading the Health Industry with "Cordyceps+"

In recent years, ecological breeding of Cordyceps sinensis has grown rapidly. Since 2007, HEC Group has invested over RMB 4 billion and built a team of 260 experts, establishing a 400,000 m² ecological base with annual output exceeding 60 tons—leading the global industrialization of Cordyceps breeding.

HEC Group has built a health industry cluster centered on raw Cordyceps and extended into deep-processed products, addressing wellness, travel convenience, and premium gifting. It has ranked first globally in ecological Cordyceps sales for five consecutive years.

Leveraging advanced deep-processing technology, the Group is developing "Cordyceps+" products aligned with global wellness trends—such as Whitening Drinks and Lung-Clearing Powder—reinterpreting traditional tonics for diverse cultural needs.

Through its partnership with JungKwanJang, HEC Group will integrate world-leading Cordyceps breeding with red ginseng deep-processing technology to create a new generation of functional health products—another forward-looking step in its "Cordyceps+" strategy.

Looking ahead, HEC Group will expand its portfolio, modernize traditional tonics, and accelerate the globalization of Eastern wellness through premium Cordyceps products and services. Singapore, as HEC Group's regional hub, will see the opening of its flagship store at the iconic Marina Bay Sands in 2026. This milestone underscores the Group's ambition to expand its global footprint in health & wellness.

SINGAPORE, Aug. 29, 2025 /PRNewswire/ -- The JungKwanJang delegation included Kim Yang-jin, Director General of the Overseas Business Division; Jung Jong, Director General of the Asia-Pacific Business Division; and Kim Jong-sik, Director of the Future Business Research Institute, along with five other representatives. HEC Group was represented by Director and General Manager Tang Xinfa; Lu Yuxin, Director and General Coordinator of the Health Industry; Li Wenjia, Deputy General Coordinator of the Health Industry and Dean of the Health Research Institute; Chen Hao, General Manager of HEC Pharmacy Chain Sales; Chen Junhao, among other corporate leaders.

Key Focal Discussions: Powerful Alliance Launches a New Chapter in the Global Health Industry

During the meeting, both sides shared their core strengths and strategies. Tang Xinfa, Director and General Manager of HEC Group, highlighted the company's focus on ecological breeding and scientific innovation of Cordyceps sinensis, while expanding its market applications. Through premium brand HEC Fresh Cordyceps and national brand HEC Buji, the group pursues its vision of "making high-quality Cordyceps accessible to all." With aligned visions and strategies, both parties look forward to synergizing across products, channels, and branding to advance the global health industry.

JungKwanJang representatives highlighted their pursuit of partners with innovation, quality, and cultural influence. Recognizing HEC Group as a global leader in ecological Cordyceps with strong achievements in research, quality, and tonic culture, they see it as an ideal partner. Together, the "Red Ginseng + Cordyceps" synergy is expected to bring the health benefits of modern technology and traditional tonics to more consumers worldwide.

Through this partnership, the two parties will establish a comprehensive strategic collaboration, leveraging their core strengths in ecological Cordyceps sinensis breeding R&D and Korean red ginseng health products. Together, they will drive the global development of premium health products.

International Perspective: Mutual Empowerment to Boost Global Branding

Amid globalization, Chinese enterprises are advancing globally with products as the foundation, brands as the wings, and culture as the soul. Within this framework, HEC Group is building a health ecosystem that bridges tradition and modernity, domestic and international markets, with Cordyceps sinensis at its core.

As a national health brand with global reach, HEC Cordyceps has steadily advanced its international strategy—partnering with the Boao Forum for Asia, appearing at high-level platforms such as the China-Arab States Cooperation Forum, and hosting the Summit Forum on Cordyceps Brand Internationalization to engage leading experts on global development.

Through this collaboration, both sides will leverage their global strengths—JungKwanJang 's presence in over 40 countries and regions and HEC Group's extensive pharmaceutical and wellness network—to accelerate cross-border circulation of health products. They will drive joint marketing, co-branded products, and expansion in China and abroad, further enhancing both brands' global influence.

Forward-looking Layout: Upgrading the Health Industry with "Cordyceps+"

In recent years, ecological breeding of Cordyceps sinensis has grown rapidly. Since 2007, HEC Group has invested over RMB 4 billion and built a team of 260 experts, establishing a 400,000 m² ecological base with annual output exceeding 60 tons—leading the global industrialization of Cordyceps breeding.

HEC Group has built a health industry cluster centered on raw Cordyceps and extended into deep-processed products, addressing wellness, travel convenience, and premium gifting. It has ranked first globally in ecological Cordyceps sales for five consecutive years.

Leveraging advanced deep-processing technology, the Group is developing "Cordyceps+" products aligned with global wellness trends—such as Whitening Drinks and Lung-Clearing Powder—reinterpreting traditional tonics for diverse cultural needs.

Through its partnership with JungKwanJang, HEC Group will integrate world-leading Cordyceps breeding with red ginseng deep-processing technology to create a new generation of functional health products—another forward-looking step in its "Cordyceps+" strategy.

Looking ahead, HEC Group will expand its portfolio, modernize traditional tonics, and accelerate the globalization of Eastern wellness through premium Cordyceps products and services. Singapore, as HEC Group's regional hub, will see the opening of its flagship store at the iconic Marina Bay Sands in 2026. This milestone underscores the Group's ambition to expand its global footprint in health & wellness.

** The press release content is from PR Newswire. Bastille Post is not involved in its creation. **

HEC Group and JungKwanJang Form Strategic Alliance to Drive a New Era in Eastern Tonic Health

HEC Group and JungKwanJang Form Strategic Alliance to Drive a New Era in Eastern Tonic Health

HEC Group and JungKwanJang Form Strategic Alliance to Drive a New Era in Eastern Tonic Health

HEC Group and JungKwanJang Form Strategic Alliance to Drive a New Era in Eastern Tonic Health

HEC Group and JungKwanJang Form Strategic Alliance to Drive a New Era in Eastern Tonic Health

LAS VEGAS, Jan. 17, 2026 /PRNewswire/ -- At CES 2026, Flowtica was not the loudest presence on the show floor. Over the course of the week, however, the Singapore-based AI company became one of the most closely watched, drawing sustained attention from media, investors, and industry observers.

That attention has now translated into availability. Following its appearance as a CES 2026 Innovation Award Honoree, Flowtica has officially opened sales of Flowtica Scribe, its AI recording pen that quietly stood out in a field dominated by phone-dependent and screen-heavy solutions.

Flowtica Scribe did not make its first public appearance at CES. The product launched on Kickstarter several months earlier, where it attracted thousands of users and established early validation. CES marked a different stage for the company. The focus shifted away from introduction and toward closer examination, with many observers asking whether the idea could hold up beyond early enthusiasm.

Throughout the exhibition, Flowtica's booth at Eureka Park became a steady meeting point for investors and journalists. Conversations rarely centered on specifications or feature lists. Instead, discussions focused on a more fundamental question: whether AI recording tools are beginning to converge on forms that genuinely fit into professional life.

Flowtica's answer was visible in its choice of form. By embedding AI into a pen, an object already accepted in boardrooms, consultations, investor meetings, and sales conversations, the company avoided many of the social and practical frictions that continue to limit phone-based recorders. The result was a device that felt less like a new category of gadget and more like a natural extension of existing behavior.

This restraint is deliberate. Flowtica Scribe is designed to remain unobtrusive, with no screen and no demand for user attention during conversations. Recording, organization, and interpretation take place quietly in the background, allowing users to remain focused on the discussion itself. Among on-site observers, this approach positioned Flowtica as one of the more pragmatic entrants in an increasingly crowded AI recording market.

Hardware, however, represents only part of Flowtica's differentiation. The company places equal emphasis on what happens after recording ends. Its AI functions as a continuously evolving insight system that can operate autonomously while remaining responsive to clear user guidance when needed. Over time, it adapts to individual working rhythms and priorities, shifting the emphasis from capturing everything to identifying what truly matters.

Rather than simply storing conversations, Flowtica helps determine which moments should be retained, revisited, and translated into next actions. Key insights are designed to integrate naturally with existing productivity tools, including calendars and task systems, allowing them to fit into established workflows rather than compete with them.

As interest in Flowtica Scribe built during CES, one question surfaced repeatedly. When would the product be available beyond the show floor?

With sales now officially open through Flowtica's website, the company moves from exhibition attention to real-world deployment. For Flowtica, this moment appears less like a conclusion and more like a transition, from being observed to being used.

As the AI recording market continues to mature, competition is shifting away from novelty and early adoption toward durability. The defining question is no longer whether a system can record conversations, but whether it can remain useful over time.

Flowtica enters this next phase with an approach that is measured and quietly confident, placing its bet not on spectacle, but on long-term relevance.

** The press release content is from PR Newswire. Bastille Post is not involved in its creation. **

The AI Recording Pen That Turned Heads at CES Is Finally for Sale